BRIEF-EMA adopts positive opinion on expanded approval of Gilead's HIV drug, Truvada
July 22, 2016 at 07:33 AM EDT
* European CHMP adopts positive opinion on Gilead's type II variation application for Truvada for reducing the risk of sexually acquired HIV.